Insiders · NPCE

Renee Ryan

Director at NeuroPace Inc (NPCE)

Renee Ryan has filed 6 insider reports with the SEC since October 2021, as director at NeuroPace Inc (NPCE). The latest filing, on June 5, 2026, reports grant or award at NeuroPace Inc (NPCE).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Renee Ryan is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
NeuroPace Inc logo
NPCE
NeuroPace Inc
Director2,890$7.95Jun 5, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Renee Ryan with

Other insiders at the same companies

Questions about Renee Ryan

What is Renee Ryan's role at NeuroPace Inc?
Renee Ryan reports to the SEC as director at NeuroPace Inc (NPCE), according to the latest filing on June 5, 2026.
How many shares does Renee Ryan own?
After the latest filing that states it, Renee Ryan directly owned 2,890 shares of NeuroPace Inc (NPCE). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Renee Ryan bought or sold stock recently?
No open-market purchases or sales by Renee Ryan are on file. The filings report grant or award.
How do I get alerts when Renee Ryan files?
Follow Renee Ryan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Renee Ryan (SEC CIK 0001855576). Totals count each trade once, skipping amendments whose original is on file, from Oct 8, 2021 on. View on SEC EDGAR · Get this as JSON